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http://dx.doi.org/10.1016/j.pedneo.2Henoch-Scho¨nlein purpura (HSP) is a disorder whose cause and pathogenesis is unknown; some
familial cases of this disease have been reported. The clinical heterogeneity in HSP may be
conferred by a number of genetic loci, including the major histocompatibility complex. The
racial and genetic factors responsible for the occurrence of the familial cases of HSP in Taiwan
are unclear. The purpose of this study was to examine the racial and genetic factors in familial
HSP cases in Taiwan. We retrospectively collected the HSP cases in our hospital during 2006
through 2010 and observed that familial HSP cases were only in Taroko Aborigines. Six cases
of HSP in 3 Taroko families were found, and their human leukocyte antigens (HLA) were studied
in the tissue typing laboratory of our hospital, to determine the possible association with
familial HSP cases in Taiwanese Aborigines. Our results suggest an increased frequency of
familial HSP cases with HLA-A24 in Taiwanese Taroko Aborigines. We concluded that racial
and genetic predisposition was the possible cause for the familial occurrence of and renal
involvement in HSP in Taiwanese Aborigines.
Copyright ª 2012, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.of Pediatrics, Buddhist Tzu Chi General Hospital, 707, Section 3, Chung-Yang Road, Hualien, Taiwan.
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Figure 1 Pedigree of Family 1. The onsets of their diseases
were, retrospectively, October and December 2008, when they
were 6 years old.
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Henoch-Scho¨nlein purpura (HSP) is a common disease in
children and adolescents, presenting as a systemic vascu-
litis whose cause is unknown. The disorder is characterized
by nonthrombocytopenic purpura, arthritis, abdominal
pain, and glomerulonephritis. This syndrome has a long
history, with early mentions by William Heberden in the
18th century.1 The annual incidence in Taiwanese children
aged <17 years is 12.9 per 100,000 children.2 However, few
cases of familial HSP have been reported, and some reports
suggest that certain types of human leukocyte antigens
(HLA-A2, HLA-A11, and HLA-B35) are related to the occur-
rence of and renal involvement in HSP.3 Although most
features of HSP are self-limiting, renal involvement is most
likely to result in long-term morbidity.4 Certain factors,
including proteinuria, female gender, and age, have also
been reported to be associated with the more severe form
of Henoch-Scho¨nlein nephritis.5,6 We found 6 cases of
familial HSP in 3 Taroko aboriginal families, and most of the
cases presented with renal involvement. The aims of the
study were to investigate the racial and genetic factors
responsible for the occurrence of familial cases of HSP.
2. Family 1
The first patient was a 6-year-old girl who initially pre-
sented with purpura over the entire body, nausea, and
vomiting. Arthralgia was absent. The blood test revealed
that the white blood cell (WBC) count was 10,970 cells/mL,
and the C-reactive protein level was 0.48 mg/dL. Antinu-
clear antibodies were all detected at a serum dilution of
<1:40. The serum levels of IgA, IgG, and IgM were 64.7,
340.4, and 47.3 mg/dL, respectively. Dipstick urinalysis
revealed occult blood (4þ) and proteinuria (3þ). The
highest value of the 24-h urine protein excretion was
9352.5 mg, and the creatinine clearance rate was
36.1 mL/min. Hypoalbuminemia and dyslipidemia (level of
low-density lipoprotein, 242 mg/dL) were noted. Hyper-
tension developed (systolic pressure, approximately
150e160 mmHg). A renal biopsy revealed crescentic
glomerulonephritis. The patient initially received 1 mg/kg
prednisolone. The symptoms fluctuated, and subse-
quently, cyclosporine was also administered; its dosage
was raised from 75 mg/day to 100 mg/day. The symptoms
improved after pulse therapy with a steroid and cyclo-
phosphamide. Hypertension was controlled by adminis-
tration of nifedipine, captopril, and furosemide, while
hyperlipidemia was controlled by administration of ator-
vastatin. However, renal involvement was still evident,
and urinalysis revealed that the red blood cell (RBC) count
was 25e30/high-power field (HPF) and 24-h proteinuria
level was 3.2 g. The HLA analysis was positive for HLAs
A02, A24, B48, B55, C03 and C08.
The second patient was a cousin of the first patientda 6-
year-old boy who initially presented with purpura over both
legs for 4 days and cough and rhinorrhoea for 1 week. A
blood test revealed that the WBC count was 19,390 cells/
mL. Antinuclear antibodies were all detected at a serum
dilution of <1:40. The serum levels of IgA and IgG were
166.8 and 1093.5 mg/dL, respectively. The levels of serumcomplements C3 and C4 were 95.4 and 20.0 mg/dL,
respectively. The patient was treated using 15 mg pred-
nisolone daily. His symptoms occasionally flared up as skin
rashes, petechiae, and arthralgia. The petechiae were
mainly distributed over the lower extremities and penis and
sometimes involved all four extremities. The creatinine
level was 0.4 mg/dL (creatinine clearance rate, 60.8 mL/
min), and the blood urea nitrogen level was 14 mg/dL.
Urinalysis revealed 20e30 RBCs/HPF. The 24 h urine protein
excretion value was <300 mg. The blood pressure was
approximately 100/80 mmHg, and it did not exceed 140/
100 mmHg. The total cholesterol level was 202 mg/dL, and
the high-density lipoprotein level was 57 mg/dL. The HLA
analysis was positive for HLAs A24, B39, B40, C03 and C07.
The family pedigree is shown in Figure 1.
3. Family 2
Two cases of HSP occurred in the second family; the two
patients were brothers.
The first patient was an 8-year-old boy who initially
presented with multiple palpable rashes over the extremi-
ties and buttocks and had experienced pain in both legs and
intermittent pain in the right upper quadrant for one week.
Hematuria was also noted by his mother at home; however,
urinalysis at our hospital later revealed 0e2 RBCs/HPF.
Upper respiratory tract infection was noted before the
onset of symptoms. The WBC count was 7200/mL, and the
C-reactive protein level was 0.22 mg/dL. The serum
creatinine level was 0.4 mg/dL. Anti-streptolysin O test
showed <1:40. Anti-nuclear antibodies were all detected at
a serum dilution of <1:40. The serum levels of IgA, IgG, and
IgM were 160.4, 955.7, and 144.9 mg/dL, respectively. The
levels of serum complements C3 and C4 were 112.2 and
27.9 mg/dL, respectively. The HLA analysis was positive for
HLAs A11, A24, B15, B40, C04 and C07. The patient was
treated using 20 mg/day prednisolone for 9 days, and the
symptoms improved.
The patient’s elder brother was a 14-year-old boy who
developed similar symptoms 3 months later. The purpura
were palpable and itchy and progressively extended from
the distal to proximal ends of both lower limbs; the patient
also experienced intermittent abdominal pain, arthralgia,
and flank pain on both sides. Cough and rhinorrhoea were
absent, and he had no known allergic history. Proteinuria
was absent; however, urinalysis revealed hematuria
Figure 3 Pedigree of Family 3. The onsets of their diseases
were, retrospectively, October 14th 2010 and November 11th
2010, when they were 11 and 8 years old. The younger
brother’s disease was precipitated by upper respiratory tract
symptoms.
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and the C-reactive protein level was 0.51 mg/dL. The
serum creatinine level was 0.6 mg/dL. Anti-streptolysin O
test showed 1:80. Antinuclear antibodies were all detected
at a serum dilution of <1:40. The serum levels of IgA, IgG,
and IgM were 210.4, 1246.2, and 123.4 mg/dL, respectively.
The levels of serum complements C3 and C4 were 130.9 and
27.1 mg/dL, respectively. The symptoms were controlled
by administration of 20 mg/day prednisolone for two
weeks.
The family pedigree is shown in Figure 2.
4. Family 3
The first patient was an 11-year-old girl who initially pre-
sented with multiple erythematous macular rashes over
bilateral feet and forearms for 2 weeks. Periumbilical dull
pain was also noted; however, the patient had no hema-
turia. The WBC count was 4320/mL, and the C-reactive
protein level was 0.83 mg/dL. The serum creatinine level
was 0.6 mg/dL. Anti-streptolysin O test showed <1:40.
Anti-nuclear antibodies were all detected at a serum dilu-
tion of <1:40. The serum levels of IgA, IgG, and IgM were
282, 1400, and 85.5 mg/dL, respectively. The levels of
serum complements C3 and C4 were 137 and 30.2 mg/dL,
respectively. The HLA analysis was positive for HLAs A02,
A24, B40, B48, C07 and C08. The patient was treated using
15 mg/day prednisolone with azathioprine 25 mg/day, and
the symptoms improved.
The patient’s younger brother was an 8-year-old boy who
developed similar symptoms1month later. Thepurpurawere
palpable and itchy and progressively extended from the
distal to proximal ends of both of the lower limbs; the patient
did not experience abdominal pain, arthralgia, or flank pain.
However, cough and rhinorrhoeawere noticed. There was no
hematuria or proteinuria. The WBC count was 10,250 cells/
mL, and the C-reactive protein level was 0.07 mg/dL. The
serum creatinine level was 0.6 mg/dL. Anti-streptolysin O
test showed 1:80. Antinuclear antibodies were all detected
at a serumdilution of<1:40. The serum levels of IgA, IgG, and
IgM were 170, 1090, and 91.2 mg/dL, respectively. The HLA
analysis was positive for HLAs A24, B40 and C07. The symp-
toms were not severe, and systemic steroid was not used.
The family pedigree is shown in Figure 3.
5. Discussion
We have reported the cases of familial HSP in 3 Taiwanese
aboriginal families (Taroko; Table 1). At least 9 otherFigure 2 Pedigree of Family 2. The onsets of their diseases
were, retrospectively, September and December 2007, when
they were 6 and 12 years old. The younger brother’s disease
was precipitated by upper respiratory tract symptoms.studies on HSP, which included 37 cases of HSP in 18 fami-
lies, have been reported since 1960,7,8 and are summarized
in Table 2.2,4,5,8,10,11,13e15,19 This finding indicates that the
disease may be hereditary in nature. However, it is
unknown whether Taiwanese aborigines, especially the
Taroko tribe, are at a higher risk of developing familial HSP;
a larger study is required to confirm this supposition.
Recent studies have indicated that individuals with HLA-A2,
HLA-A11, and HLA-B35 are more susceptible to HSP.3
Additionally, some researchers have also discovered that
individuals with HLA-B35 are prone to have renal involve-
ment.3 Among the patients in this report, one had severe
renal impairment and developed nephrotic syndrome.
Three patients had hematuria without proteinuria.
However, these HLA types are less prevalent among
Taiwanese aborigines,9,10 and the HLA typing for our
patients revealed only two patients had HLA-A2 and no
patient had HLA-B35. Other HLA types that favor familial
HSP development may exist; for example, most of our
patients had HLA-A24. Further analysis of the HLAs of
individuals from the families might be helpful in identifying
the incidence of HSP in the Taroko tribe and the suscepti-
bility of this tribe to the disease.
The onset of HSP was similar in the cases described
above. This might be attributed to the environmental
nature of HSP. Recent studies have suggested that HSP
might be related to the bites of certain insects.11 In these
patients, this might be related to the environment that
they live in; the aborigines live in the mountains and are
much more susceptible to insect bites. However, further
investigation into the relationship between these risks is
essential. The 8-year-old boys in the second and third
families had upper respiratory tract infection before the
symptoms of HSP developed. This might be another pre-
disposing factor, although this was not observed in the
other 4 cases reported.
Comparing our six patients to those cases previously
reported listed in Table 2, the onset intervals were much
longer in the literature, and there were some extreme ages
such as 32 and 51 years old. This may be explained by the
different genetics between different races, and the
different environments in which they live. The environment
in which aborigines live in eastern Taiwan is more consis-
tent and thus, the environmental exposures in our cases
were similar. This may explained the time of onset being
Table 1 Clinical characteristics of the six HSP patients in three families.
Patient Sex Age of
onset






1 F 6 þ A02, A 24, B48, B55, C03, C08 A 24 
2 (cousin of
Patient 1)
M 6 þ A24, B39, B40, C03, C07 A 24 þ 2 months
after patient 1
3 M 8  A11, A24, B15, B40, C04, C07 A 24 þ
4 (older brother
of Patient 3)
M 14 þ  3 months
after patient 3
5 F 11  A02, A24, B40, B48, C07, C08 A 24 
6(younger brother
of Patient 5)
M 8  A24, B40, C07 A 24 þ 1 month
after patient 5
Table 2 Familial cases of HenocheScho¨nlein purpura reported from 1960 to 2011.
Author Familial case Age of onset (y) Interval of onset Others
Allen12 Two siblings in one family Unknown Unknown Unknown
Meadow13 Two sisters in one family 6 and 12 9 y Unknown
Lofters14 Father and two daughters 8, 16, and 51 >2 y Nephritis in father
Mizuno15 Two siblings in one family Unknown Unknown Two with renal failure
Farley16 Two siblings in one family Unknown Unknown Unknown
Levy17 Two sisters with HSP, one brother
and one first cousin with IgAN
11 and 14 8 y One with ESRD
Cakir18 Two siblings in one family Unknown 2 mo Prisoners in same jail
Motoyama8 Eight families with 16 cases of HSP 3e32 wk to 5 y Three cases of hematuria
Balbir-Gurman19 One brother and one
sister in one family
30 and 23 10 y With familial
Mediterranean fever
Yang Zhang7 Two families with 4 cases 7, 15, 16 and 18 1 mo and 10 mo
Familial cases of Henoch-Scho¨nlein purpura 323much close between cases in their families. In addition, the
familial cases shown in Table 2 were not aborigines. Since
aborigines are a group with more confined genetic traits,
identifying common HLA for a specific familial disease is
more significant.
In summary, we here have reported 6 cases of familial
HSP in 3 Taroko families, most of whom had renal involve-
ment. Although the HLA typing of our patients did not
correlate well with those susceptible HLAs types reported
in previous literature, this could suggest that there are
more HLA types susceptible to HSP. Further investigation is
needed to find out which HLA type is prone to HSP, and this
can be an indication for those patients to avoid other
environmental triggers of this disease.References
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